ArticleBiosensors2025
A Novel Wearable Device for Continuous Blood Pressure Monitoring Utilizing Strain Gauge Technology.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Latent profile analysis and influencing factors of proactive health behaviors in hypertensive patients from the perspective of the health belief model.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Cardiovascular disease (CVD) is the leading cause of global mortality, with hypertension affecting over one billion people. Current noninvasive blood pressure (BP) systems, like cuffs, suffer from discomfort and placement errors and lack continuous monitoring. Wearable solutions promise improvements, but technologies like photoplethysmography (PPG) and bioimpedance (BIOZ) face usability and clinical accuracy limitations. PPG is sensitive to skin tone and body mass index (BMI) variability, while BIOZ struggles with electrode contact and reusability. We present a novel, strain gauge-based wearable BP device that directly quantifies pressure via a dual transducer system, compensating for tissue deformation and external forces to enable continuous, accurate BP measurement. The reusable, energy-efficient, and compact design suits long-term daily use. A novel leg press protocol across 10 subjects (systolic: 71.04-241.42 mmHg, diastolic: 53.46-123.84 mmHg) validated its performance under dynamic conditions, achieving mean absolute errors of 2.45 ± 3.99 mmHg (systolic) and 1.59 ± 2.08 mmHg (diastolic). The device showed enhanced robustness compared to the Finapres, with less motion-induced noise. This technology significantly advances current methods by delivering continuous, real-time BP monitoring without reliance on electrodes, independent of skin tone, while maintaining a high accuracy and user comfort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.